Literature DB >> 8348749

Effects of tumour necrosis factor-alpha (TNF-alpha), IL-1 beta and monocytes on lymphokine-activated killer (LAK) induction from natural killer (NK) cells and T lymphocytes.

K Yoneda1, T Osaki, T Yamamoto, E Ueta.   

Abstract

Roles of monocytes and cytokines were investigated on LAK induction from T and NK cells. Monocytes augmented more T-LAK induction than did NK-LAK. Expression of IL-1 beta, TNF-alpha and interferon-gamma (IFN-gamma)-mRNA and their cytokine production were superior in NK cells compared with T cells in parallel with their LAK activities. An increase of TNF-alpha, IL-1 beta and IFN-gamma production was induced by co-culturing NK or T cells with autologous monocytes. The augmentation of T cell cytokine production and T-LAK activity by monocytes was more prominent than that of NK cells. TNF-alpha and IL-1 beta were generated 24 h after IL-2 stimulation, and these cytokines were able to almost substitute for monocytes in LAK induction. Conversely, LAK induction was almost completely suppressed by both anti-IL-1 beta and anti-TNF-alpha antibodies, if they were added within 24 h after the start of the LAK induction. IFN-gamma, which was produced at a later stage, scarcely affected LAK induction in spite of the cooperation with TNF-alpha. The results obtained indicate conclusively that the superiority of NK-LAK depends on their superior productivity of both IL-1 beta and TNF-alpha, and that the up-regulation of LAK induction by monocytes is largely due to the enhanced generation of both cytokines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348749      PMCID: PMC1554840          DOI: 10.1111/j.1365-2249.1993.tb07971.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma.

Authors:  F Farace; C Mathiot; M Brandely; T Tursz; T Dorval; P Pouillart; F Triebel; T Hercend; W H Fridman
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Regulation of lymphocyte tumor necrosis factor receptors by IL-2.

Authors:  L B Owen-Schaub; W L Crump; G I Morin; E A Grimm
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

3.  Synergy of human recombinant interleukin 1 with interleukin 2 in the generation of lymphokine-activated killer cells.

Authors:  W L Crump; L B Owen-Schaub; E A Grimm
Journal:  Cancer Res       Date:  1989-01-01       Impact factor: 12.701

4.  Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment.

Authors:  G Boccoli; R Masciulli; E M Ruggeri; P Carlini; G Giannella; E Montesoro; G Mastroberardino; G Isacchi; U Testa; F Calabresi
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

5.  Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.

Authors:  S Chouaib; J Bertoglio; J Y Blay; C Marchiol-Fournigault; D Fradelizi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.

Authors:  L Rivoltini; C Gambacorti-Passerini; M Squadrelli-Saraceno; M I Grosso; G Cantù; R Molinari; A Orazi; G Parmiani
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

7.  Accessory cells, dendritic cells, or monocytes, are required for the lymphokine-activated killer cell induction from resting T cell but not from natural killer cell precursors.

Authors:  O Silvennoinen; J Vakkila; M Hurme
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

8.  Tumor necrosis factor-induced downregulation of its receptors in HeLa cells.

Authors:  M Tsujimoto; J Vilcek
Journal:  J Biochem       Date:  1987-12       Impact factor: 3.387

9.  Prerequisite for the induction of lymphokine-activated killer cells from T lymphocytes.

Authors:  H Sawada; T Abo; S Sugawara; K Kumagai
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

10.  Functional interactions of IL2 and TNF in the differentiation of LGL into LAK effectors.

Authors:  J Y Blay; J Bertoglio; D Fradelizi; S Chouaib
Journal:  Int J Cancer       Date:  1989-10-15       Impact factor: 7.396

View more
  2 in total

1.  Early effects of low dose C ion or x-ray irradiation on peripheral blood lymphocytes of patients with alimentary tract cancer.

Authors:  Yingtai Chen; Xuezhong Chen; Yumin Li; Hong Zhang; Yi Xie; Xiaowei Zhang; Huizi Ren; Yanling Wang; Shiqi Liao; Mingyan He; Jinyu Ren; Jieyu Zhang; Xiadong Zhou; Tongzhang Zheng; Briseis A Kilfoy; Yawei Zhang
Journal:  Dose Response       Date:  2010-08-02       Impact factor: 2.658

2.  Tumour necrosis factor-alpha enhances intraepithelial lymphocyte proliferation and migration.

Authors:  E C Ebert
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.